Interested in participating in a clinical trial?
Researchers are testing a new investigational treatment called tibulizumab in a study to see if it can reduce bumps and abscesses in people who are affected with this condition.
Participants aged 18 to 70 years with hidradenitis suppurativa are being invited to participate in this study, which will last approximately 45 weeks with 13 visits in total.
If you participate in this study, you will be provided with all study medication, examinations, and medical care related to the study free of charge.
This is a Phase 2 study with locations across the globe.
For more information and to see if you qualify, visit https://clinago.life/study/hidradenitis-suppurativa-z-hs02?id=32 .
Questions? Contact clinicaltrial@zurabio.com.